These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 19692457

  • 1. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
    Wallin L, Quintilio W, Locatelli F, Cassel A, Silva MB, Skare TL.
    Acta Reumatol Port; 2009 Jul; 34(3):498-502. PubMed ID: 19820674
    [Abstract] [Full Text] [Related]

  • 4. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

  • 5. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D.
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [Abstract] [Full Text] [Related]

  • 6. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

  • 7. Influenza vaccination of patients with systemic lupus erythematosus.
    Mercado U, Acosta H, Avendaño L.
    Rev Invest Clin; 2004 Jul; 56(1):16-20. PubMed ID: 15144037
    [Abstract] [Full Text] [Related]

  • 8. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
    Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong DB, Wechsler B, Hervier B, Miyara M, Morel N, Le Corre N, Arnaud L, Piette JC, Musset L, Autran B, Rozenberg F, Amoura Z.
    Arthritis Rheum; 2011 Nov; 63(11):3502-11. PubMed ID: 21811996
    [Abstract] [Full Text] [Related]

  • 10. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
    [Abstract] [Full Text] [Related]

  • 11. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
    Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D.
    J Rheumatol; 2000 Jul; 27(7):1681-5. PubMed ID: 10914851
    [Abstract] [Full Text] [Related]

  • 12. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 13. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul 19; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 14. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 15. Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination.
    Holvast A, Stegeman CA, Benne CA, Huckriede A, Wilschut JC, Palache AM, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2009 Jun 27; 68(6):873-8. PubMed ID: 18625625
    [Abstract] [Full Text] [Related]

  • 16. Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.
    de Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, Banzhoff A, Pletz MW, Lode H.
    Vaccine; 2006 Mar 06; 24(10):1537-42. PubMed ID: 16288937
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P.
    Am J Kidney Dis; 2009 Jul 06; 54(1):77-85. PubMed ID: 19339089
    [Abstract] [Full Text] [Related]

  • 18. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

  • 19. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, Spighi M.
    Gerontology; 2007 Apr 12; 53(6):411-8. PubMed ID: 17975317
    [Abstract] [Full Text] [Related]

  • 20. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
    Trmal J, Havlícková M, Bícová R, Bitterová Z, Kelerová J.
    Epidemiol Mikrobiol Imunol; 2005 Aug 12; 54(3):123-8. PubMed ID: 16173523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.